Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Change-To-Inventory" stands at -25.79 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Takeda Pharmaceutical Co. Ltd.'s second quarter result of -28.96 Billion JPY for the item "Change To Inventory" represents a decrease of -121.61 percent compared to it's first quarter result.
Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of -28.96 Billion JPY for the item "Change To Inventory" represents an increase of 29.60 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of -25.79 Billion JPY for the item "Change To Inventory" represents an increase of 32.08 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 63.24 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 63.24 Billion Japanese Yens.
The 3 year change is 11.18 Billion Japanese Yens.
The 5 year change is -95.31 Billion Japanese Yens.
The 10 year change is -16.86 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change To Inventory | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change To Inventory | 486,508,953,600.00 |
![]() | AbbVie Inc - Change To Inventory | 399,570,305,024.00 |
![]() | Roche Holding AG - Change To Inventory | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change To Inventory | 280,205,508,085.11 |